The federal government won't move psilocybin to a less restricted category before January 2028, even if Congress pushes hard or new research comes out. The actual rescheduling process takes 18–24 months minimum and involves the DEA (Drug Enforcement Administration), HHS (Department of Health and Human Services), a public comment period, and final paperwork — and nobody has even formally started yet.
Administrative rescheduling requires sequential DEA concurrence, HHS review, public comment period, and final rule publication — a process that takes a minimum of 18-24 months from formal initiation. No formal initiation has begun as of June 2026. The procedural math makes pre-2028 rescheduling structurally impossible, independent of political will. Confidence is high but not certain because an emergency scheduling action (unprecedented for controlled substances moving down schedules) remains a theoretical tail risk.